Get started
CLICKS GROUP LTDCLICKS GROUP LTDCLICKS GROUP LTD

CLICKS GROUP LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

CLS trade ideas

Our opinion on the current state of CLICKS(CLS)Clicks Group describes itself as a retail-led healthcare group, comprising its flagship brand Clicks, as well as GNC and The Body Shop. It operates 782 stores, 585 of which include pharmacies, making it the largest pharmacy chain in Southern Africa. Despite the increasing trend of retail outlets incorporating pharmacies, Clicks' main competitor remains the listed company, Dischem. A previous challenge for the group was its association with the fifty-nine Musica stores, which have now been closed. On 10th May 2021, Clicks made a significant expansion by acquiring the pharmacy business of Pick n Pay, which included twenty-five pharmacies located within Pick 'n Pay stores. These pharmacies are being rebranded to Clicks, further solidifying its market presence. Historically, Clicks has shown remarkable stability and growth; the share price has surged by more than 2500% since its listing, significantly outperforming the JSE's average over the same period. This performance underscores Clicks as one of the top blue-chip shares on the JSE. The company has demonstrated resilience, proving to be relatively recession-proof and continuing to deliver impressive results. For the six months ending on 29th February 2024, Clicks reported a 9% increase in turnover and a 13% rise in headline earnings per share (HEPS). The company highlighted a 14.1% growth in total income to R6.6 billion, driven by strong sales in higher-margin private label products and the beauty category, along with revenue from Sorbet franchise fees. Despite its high price-to-earnings (P/E) ratio of 27.37, Clicks is viewed as an excellent medium-term investment, suitable for every private investor's portfolio. The share's consistent upward trajectory over the past 15 years resembles a line moving from the bottom left-hand corner of the screen to the top right-hand corner, illustrating its steady growth. Although the share price has experienced a slight decline since the beginning of 2024, this could present a favorable buying opportunity for investors.
JSE:CLS
by PDSnetSA
CLS: Rebounding from crucial support levels?A price action above 30000 supports a bullish trend direction. Further bullish confirmation for a break above 308000 (its 23.6% Fibonacci retracement level). The target price is set at 32000. The stop-loss price is set at 28700. Remains above key support (see the black dotted trendline). Remains above its 200-day and 200-week simple moving averages, supporting a bullish underlying trend. Classified as a technical trading opportunity.
JSE:CLSLong
by Peet_Serfontein
Our opinion on the current state of CLSClicks (CLS) describes itself as a retail-led healthcare group. It incorporates Clicks, GNC and The Body Shop. Clicks has 782 stores of which 585 include pharmacies - which makes Clicks the largest pharmacy chain in Southern Africa. Although more retail outlets are installing pharmacies in their shops, the listed Dischem is Clicks main competitor. Probably the only negative about this company was its involvement with the fifty-nine stores of Musica, which it has now closed. On 10th May 2021 the company announced that it had acquired the pharmacy business of Pick n Pay - which consists of twenty-five pharmacies located inside Pick 'n Pay stores. These will now be re-branded to Clicks stores. Technically, the share has been a steady performer over the past 20 years. Its share price has risen by more than 2500% since it listed - which compares very well with the JSE's average over the same period. We regard this as one of the best blue-chip shares trading on the JSE. It has proven that it is more-or-less recession-proof and continues to perform remarkably well. In its results for the year to 31st August 2023 the company reported group turnover up 8,2% and headline earnings per share (HEPS) up 11,5%. The company said, "Strong growth in private label sales and the sustained recovery in the beauty category were supported by the Clicks ClubCard loyalty programme which has grown to 10.4 million active members". In a trading update for the 20 weeks to 14th January 2024 the company reported retail turnover up 11,8% and group turnover up 8%. The company said, "...growth in Clicks was driven by strong festive season trading, with Clicks achieving its highest ever daily sales on Friday 22 December 2023. The week preceding Christmas was a record trading week for the chain". As a result of its high rating, the share trades on a P:E of 29,04 - but we believe that it remains an excellent medium-term investment which should find a place in every private investor's portfolio. It is what we refer to as a "diagonal" share because over the past 15 years its chart goes from the bottom left-hand corner of your screen to the top right-hand corner. The share price has come off slightly since the start of 2024 and could be at or close to a good buying point.
JSE:CLS
by PDSnetSA
CLICKS JSE FORECAST Q3 2023 Clicks Group Limited reported earnings results for the half year ended February 28, 2023. For the half year, the company reported sales was ZAR 20,005.79 million compared to ZAR 19,557.6 million a year ago. Net income was ZAR 1,151.76 million compared to ZAR 1,205.68 million a year ago. Basic earnings per share from continuing operations was ZAR 4.721 compared to ZAR 4.928 a year ago. Diluted earnings per share from continuing operations was ZAR 4.721 compared to ZAR 4.928 a year ago. Maintaining a constant equity with a 56% debt to equity ratio im expecting a reversal of price at on of the two levels if price breaks 25629 and a setup presents itself im going lower and taking the short 13% then i will go long at the next level Here we take a closer look at the daily where a text book bullish continuation is to be expected from the creation of higher highs and lower lows and the fact that price is retesting our level after breaking it as for a short(-13%) a break and retest for the down side will serve as indication to short adding on to our equity for the second bullish attempt at the next level
JSE:CLSLong
by Bekiumuzi_Dube
CLSThis is a 2-day chart. The share is higher by 22% from the buy/long signal as per the tactical trading Guide on end of day on Friday 20 October (proof of reading can be provided, just ask!). As per the Tactical Trading Guide, the end of day SHORT TERM reading is currently as follows: "Would not enter a buy/long at current levels. The reward-to-risk is unattractive". Simultaneously, the share is trading at the upper boundary of it's 50-day 2 standard deviation linear regression channel, which supports my view that the reward-to-risk does NOT favour buyers of the share at current levels. The upward momentum is strong and there is a possibility that the share could trade higher on today (Friday), however failing to hold the prior session highs (using the high of day as a pivot) could open up a bearish reversal trade!
JSE:CLS
by techpers
Our opinion on the current state of CLSClicks (CLS) describes itself as a retail-led healthcare group. It incorporates Clicks, GNC and The Body Shop. Clicks has 782 stores of which 585 include pharmacies - which makes Clicks the largest pharmacy chain in Southern Africa. Although more retail outlets are installing pharmacies in their shops, the listed Dischem is Clicks main competitor. Probably the only negative about this company was its involvement with the fifty-nine stores of Musica, which it has now closed. On 10th May 2021 the company announced that it had acquired the pharmacy business of Pick n Pay - which consists of twenty-five pharmacies located inside Pick 'n Pay stores. These will now be re-branded to Clicks stores. Technically, the share has been a steady performer over the past 20 years. Its share price has risen by more than 2500% since it listed - which compares very well with the JSE's average over the same period. We regard this as one of the best blue-chip shares trading on the JSE. It has proven that it is more-or-less recession-proof and continues to perform remarkably well. In its results for the year to 31st August 2023 the company reported group turnover up 8,2% and headline earnings per share (HEPS) up 11,5%. The company said, "Strong growth in private label sales and the sustained recovery in the beauty category were supported by the Clicks ClubCard loyalty programme which has grown to 10.4 million active members". As a result of its high rating, the share trades on a P:E of 25,33 - but we believe that it remains an excellent medium-term investment which should find a place in every private investor's portfolio. It is what we refer to as a "diagonal" share because over the past 15 years its chart goes from the bottom left-hand corner of your screen to the top right-hand corner. The share price has come off somewhat since May 2022 and could be at or close to a good buying point.
JSE:CLS
by PDSnetSA
Clicks Climbing Wall of Worry for BullsClicks is in a bullflag that will culminate in a cycle low, the share needs to have 8 September as a cycle low for it to remain right translated (somewhat bullish). For price to confirm a yearly low we need to close above the green resistance on a monthly basis, a tall order. Earnings come in week 21, which is close to a cycle top & a time for an expected daily cycle high. We can sort of guess earnings will not please investors. Ideally we would want Clicks to resume a bearish move and go lower than 31 May low, this resets the yearly cycle and give bulls room for another shot at long position. For now we watch price action.
JSE:CLS
by runyamhere
UPDATE You pay less for Clicks for NOW target still R340You pay less at Clicks but the price is going up so now is the best time to buy. We have an Inverse Head and Shoulders pattern form, as I mentioned earlier. the price broke up and is showing strong upside to come. We have other indicators confirming including: 7>21>200 RSI>50 Target R340.76 ABOUT THE COMPANY Clicks is a well-known South African retail pharmacy, health, and beauty chain. Clicks was founded in 1968 in Cape Town, South Africa, as a health and beauty retail store. Product Range: Clicks offers a wide range of products, including pharmaceuticals, over-the-counter medications, beauty products, skincare, haircare, personal care items, and more. Store Network: Clicks has a vast network of stores across South Africa, with locations in cities, suburbs, and shopping malls. Pharmacy Services: Many Clicks stores have an in-house pharmacy, providing prescription medications, advice from qualified pharmacists, and other pharmaceutical services. Private Label Products: Clicks has its own private-label brands for various products, offering customers affordable alternatives to well-known brands. Wellness Clinics: Some Clicks stores have wellness clinics that offer various healthcare services, including vaccinations, screenings, and family planning consultations. Beauty Services: Some larger Clicks stores offer beauty services such as nail bars and eyebrow threading, enhancing the shopping experience. Online Shopping: Clicks offers an online platform where customers can shop for a wide range of products and have them delivered to their homes. Rewards Program: The Clicks ClubCard loyalty program offers customers discounts, cashback rewards, and personalized offers based on their shopping habits. Parent Company: Clicks is part of the Clicks Group, which also owns other retail brands like Musica, The Body Shop, and UPD (United Pharmaceutical Distributors). HOW IT GOT ITS NAME The "Clicks" name was apparently derived from the sound that the founder, Jack Goldin, heard from a clicking stethoscope, embodying the health focus he wanted for the company. However, due to the existing legislation, the health focus was not immediately realized until later years.
JSE:CLSLong
by Timonrosso
Clicks ($JSECLS) Seeking Monthly LowsClicks has been trending downwards, now price has reached the pink upward slopping trendline just below the 200 week moving average. Here we are looking for a swing low on the weekly time frame to confirm the trend has changed & this is cemented by price closing above the blue trendline. More risk accepting investors can buy on the swing low while those seeking more confirmation can wait for the blue trendline. To confirm that price is in a new monthly cycle, price will have to close above the green trendline so there will be a good opportunity to hold for a longer-term.
JSE:CLSLong
by runyamhere
Clicks broke above the Inverse Head and Shoulders FINALLYInverse Head and Shoulders has been forming with Clicks since March 2023 as it was being formed. We've seen the price making higher lows, breakout of its year downtrend, and things are now looking better for the bulls. Other indicators confirm: 7>21>200 RSI>50 Target 1 will be quite extended and it could be a medium term hold but my first price is to R340.76 ABOUT THE COMPANY Clicks Group is a retail-led healthcare group which has been listed on the JSE Limited (Johannesburg Stock Exchange) since 1996. Clicks Group was established in 1968 in Cape Town, South Africa by entrepreneur, Jack Goldin. Clicks was originally conceived as a drugstore concept in the style of American retailers such as Walgreens and CVS, but with legislation in South Africa at the time prohibiting corporate ownership of pharmacies, the model had to be adjusted to a variety retailer. The first Clicks store was opened in St. Georges Street in Cape Town. The "Clicks" name was apparently derived from the sound that the founder, Jack Goldin, heard from a clicking stethoscope, embodying the health focus he wanted for the company. However, due to the existing legislation, the health focus was not immediately realized until later years. The Group operates through multiple retail brands like Clicks, GNC, The Body Shop, Claire's, Musica (which you can't find anymore), and more, providing a wide array of products from health and beauty to homewares. In 2003, Clicks was finally able to introduce pharmacies into their stores after South African legislation changed to allow corporate pharmacy ownership. Clicks Group has the largest retail pharmacy chain in South Africa with over 500 in-store pharmacies.
JSE:CLSLong
by Timonrosso
$JSECLS - Clicks: Technical Reasons To Be BearishClicks has forever been a darling of the JSE. After over a decade of steady gains, the share is starting to show some cracks. From mid-2018 to just recently, price was trading more choppy and contained in a ascending channel. Price has recently broken and closed below the lower support trendline of the channel indicating that the bears have wrestled control. More significantly, price has always held above the 200W EMA but now has broken below it for the first time in over a decade. The MACD, which earlier gave a bearish divergence signal, is trading at its lowest level in over a decade, further indicating share weakness. It is still early days but I believe shorting the rallies is the way to go in the short-term.
JSE:CLSShort
by Loyiso_BlaqueSoros_Mpeta
Clicks (CLS) Potential DownturnClicks is in a bearish trend with price restricted by the resistance line. The expectation is for price to continue trending down & break below the lower support line. At the same time RSI 14 (not shown here) should reach oversold conditions & turn upwards. If price goes below 26 September low then the major trend becomes bearish. After price makes a swing low and broken the lower trendline long positions can be sold & turned short when price makes a swing high above the current resistance level. The lower blue trendline would come into scope.
JSE:CLSShort
by runyamhere